- Home
- MGRM vs XTNT Comparison
MGRM vs XTNT Comparison
Compare MGRM & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGRM
- XTNT
- Stock Information
- Founded
- MGRM 2016
- XTNT N/A
- Country
- MGRM United States
- XTNT United States
- Employees
- MGRM N/A
- XTNT N/A
- Industry
- MGRM Medical/Dental Instruments
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MGRM Health Care
- XTNT Health Care
- Exchange
- MGRM Nasdaq
- XTNT Nasdaq
- Market Cap
- MGRM 85.1M
- XTNT 83.2M
- IPO Year
- MGRM N/A
- XTNT N/A
- Fundamental
- Price
- MGRM $2.32
- XTNT $0.59
- Analyst Decision
- MGRM Strong Buy
- XTNT Strong Buy
- Analyst Count
- MGRM 1
- XTNT 1
- Target Price
- MGRM $4.00
- XTNT $3.00
- AVG Volume (30 Days)
- MGRM 34.4K
- XTNT 50.3K
- Earning Date
- MGRM 03-14-2025
- XTNT 03-31-2025
- Dividend Yield
- MGRM N/A
- XTNT N/A
- EPS Growth
- MGRM N/A
- XTNT N/A
- EPS
- MGRM N/A
- XTNT N/A
- Revenue
- MGRM $364,999.00
- XTNT $113,862,000.00
- Revenue This Year
- MGRM N/A
- XTNT $31.27
- Revenue Next Year
- MGRM N/A
- XTNT $13.07
- P/E Ratio
- MGRM N/A
- XTNT N/A
- Revenue Growth
- MGRM N/A
- XTNT 45.11
- 52 Week Low
- MGRM $1.53
- XTNT $0.33
- 52 Week High
- MGRM $4.90
- XTNT $1.30
- Technical
- Relative Strength Index (RSI)
- MGRM 33.75
- XTNT 52.36
- Support Level
- MGRM $2.32
- XTNT $0.55
- Resistance Level
- MGRM $2.57
- XTNT $0.62
- Average True Range (ATR)
- MGRM 0.17
- XTNT 0.05
- MACD
- MGRM -0.06
- XTNT -0.01
- Stochastic Oscillator
- MGRM 0.00
- XTNT 41.76
About MGRM Monogram Orthopaedics Inc.
Monogram Technologies Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.